IP waiver won’t solve vaccine problems, warn experts

A landmark proposal to suspend provisions of TRIPS for COVID-19 vaccines and treatments was first raised in October 2020. But, nearly a year and a half later, in January 2022, it seems there is no end in sight, with members of the World Trade Organization (WTO) failing to reach consensus.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Africa

MSF urges South Africa to open access to COVID-19 generics

10 February 2022 Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

Big Pharma

US, EU, India and South Africa reach COVID waiver ‘compromise’

16 March 2022 The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.

Americas

COVID-19 IP waiver faces uncertain future

31 March 2022 The future of the IP waiver related to the COVID-19 vaccine looks uncertain after the US Trade Representative confirmed no agreements had yet been reached between US, the EU, India and South Africa.

More on this story

Africa

MSF urges South Africa to open access to COVID-19 generics

10 February 2022 Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

Big Pharma

US, EU, India and South Africa reach COVID waiver ‘compromise’

16 March 2022 The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.

Americas

COVID-19 IP waiver faces uncertain future

More on this story

Africa

MSF urges South Africa to open access to COVID-19 generics

10 February 2022 Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

Big Pharma

US, EU, India and South Africa reach COVID waiver ‘compromise’

16 March 2022 The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.

Americas

COVID-19 IP waiver faces uncertain future